EXTENDING ADJUVANT TEMOZOLOMIDE LONGER THAN SIX CYCLES DOESN'T ADD ANY BENEFIT TO GLIOBLASTOMA PATIENTS ACCORDING TO THE RANDOMIZED GEINO-014 TRIAL
No Thumbnail Available
Identifiers
Date
2019-08-01
Authors
Balana, C.
Sepulveda, J.
Pineda, E.
Vaz, M.
Mesia, C.
Fuster, J.
Girones, R.
Munoz-Langa, J.
Navarro, M.
Alonso, M.
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Oxford univ press inc